These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 12861401

  • 21. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial.
    Ohkusa T, Takashimizu I, Fujiki K, Suzuki S, Shimoi K, Horiuchi T, Sakurazawa T, Ariake K, Ishii K, Kumagai J, Tanizawa T.
    Ann Intern Med; 1998 Nov 01; 129(9):712-5. PubMed ID: 9841603
    [Abstract] [Full Text] [Related]

  • 22. Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial.
    Honda M, Hiki N, Nunobe S, Ohashi M, Kumagai K, Hashimoto Y, Mine S, Kamiya S, Sano T, Yamaguchi T.
    J Am Coll Surg; 2015 Aug 01; 221(2):273-9. PubMed ID: 26141464
    [Abstract] [Full Text] [Related]

  • 23. Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.
    Kim YI, Cho SJ, Lee JY, Kim CG, Kook MC, Ryu KW, Kim YW, Choi IJ.
    Cancer Res Treat; 2016 Jul 01; 48(3):1020-9. PubMed ID: 26582396
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients.
    Kubota K, Shimizu N, Nozaki K, Takeshita Y, Ueda T, Imamura K, Hiki N, Yamaguchi H, Shimoyama S, MaFune K, Kaminishi M.
    Dig Dis Sci; 2005 May 01; 50(5):842-6. PubMed ID: 15906755
    [Abstract] [Full Text] [Related]

  • 25. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
    Maconi G, Parente F, Russo A, Vago L, Imbesi V, Bianchi Porro G.
    Am J Gastroenterol; 2001 Feb 01; 96(2):359-66. PubMed ID: 11232676
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T, Kawai T, Masaoka T, Suzuki H, Ito M, Kawamura Y, Tokunaga K, Suzuki M, Mine T, Takahashi S, Sakaki N.
    Helicobacter; 2006 Jun 01; 11(3):152-8. PubMed ID: 16684262
    [Abstract] [Full Text] [Related]

  • 27. [Eradication effect of lansoprazole-based triple therapy against H. pylori].
    Sugiyama T, Asaka M.
    Nihon Rinsho; 2004 Mar 01; 62(3):483-8. PubMed ID: 15038091
    [Abstract] [Full Text] [Related]

  • 28. [Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
    Shimizu N, Kubota K, Kaminishi M.
    Nihon Rinsho; 2005 Nov 01; 63 Suppl 11():478-81. PubMed ID: 16363583
    [No Abstract] [Full Text] [Related]

  • 29. Usefulness of Helicobacter pylori eradication for precancerous lesions of the gastric remnant.
    Sakakibara M, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, Morise K, Maeda K, Matsushita M, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Goto H.
    J Gastroenterol Hepatol; 2014 Dec 01; 29 Suppl 4():60-4. PubMed ID: 25521735
    [Abstract] [Full Text] [Related]

  • 30. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A, Ahuja V, Bal CS, Das B, Pandey RM, Sharma MP.
    Helicobacter; 2004 Apr 01; 9(2):124-9. PubMed ID: 15068413
    [Abstract] [Full Text] [Related]

  • 31. Does pretreatment with lansoprazole influence Helicobacter pylori eradication rate and quality of life?
    Inoue M, Okada H, Hori S, Kawahara Y, Kawano S, Takenaka R, Toyokawa T, Onishi Y, Shiratori Y, Yamamoto K.
    Digestion; 2010 Apr 01; 81(4):218-22. PubMed ID: 20090337
    [Abstract] [Full Text] [Related]

  • 32. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J, Mour J.
    Hepatogastroenterology; 1999 Apr 01; 46(27):2048-56. PubMed ID: 10430396
    [Abstract] [Full Text] [Related]

  • 33. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A, Miwa H, Kawabe M, Kurosawa A, Asaoka D, Hojo M, Iijima K, Terai T, Ohkusa T, Miyazaki A, Sato N.
    J Gastroenterol; 2004 Nov 01; 39(11):1051-5. PubMed ID: 15580397
    [Abstract] [Full Text] [Related]

  • 34. [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
    Kagaya H, Kato M, Asaka M.
    Nihon Rinsho; 2002 Feb 01; 60 Suppl 2():455-9. PubMed ID: 11979827
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.
    Clin Ther; 2008 Mar 01; 30(3):528-34. PubMed ID: 18405790
    [Abstract] [Full Text] [Related]

  • 36. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG, Lee DH, Ye BD, Lee KH, Kim BW, Kim SG, Kim SW, Kim SK, Kim JJ, Kim HY, Park JJ, Park CY, Baik GH, Lee YC, Lee JH, Lee JH, Chun HJ, Hahm KB, Hong SJ, Lee SW, Jung HC.
    Helicobacter; 2007 Feb 01; 12(1):31-5. PubMed ID: 17241298
    [Abstract] [Full Text] [Related]

  • 37. Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
    Kawai T, Takahashi S, Suzuki H, Sasaki H, Nagahara A, Asaoka D, Matsuhisa T, Masaoaka T, Nishizawa T, Suzuki M, Ito M, Kurihara N, Omata F, Mizuno S, Torii A, Kawakami K, Ohkusa T, Tokunaga K, Mine T, Sakaki N.
    J Gastroenterol Hepatol; 2014 Dec 01; 29 Suppl 4():29-32. PubMed ID: 25521730
    [Abstract] [Full Text] [Related]

  • 38. Inflammation of the gastric remnant after gastrectomy: mucosal erythema is associated with bile reflux and inflammatory cellular infiltration is associated with Helicobacter pylori infection.
    Lee Y, Tokunaga A, Tajiri T, Masuda G, Okuda T, Fujita I, Kiyama T, Yoshiyuki T, Kato S, Matsukura N, Yamada N.
    J Gastroenterol; 2004 Jun 01; 39(6):520-6. PubMed ID: 15235868
    [Abstract] [Full Text] [Related]

  • 39. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
    Lara LF, Cisneros G, Gurney M, Van Ness M, Jarjoura D, Moauro B, Polen A, Rutecki G, Whittier F.
    Arch Intern Med; 2003 Sep 22; 163(17):2079-84. PubMed ID: 14504122
    [Abstract] [Full Text] [Related]

  • 40. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
    Kawano S, Murakami M, Saita H, Tsuji S.
    J Gastroenterol; 1996 Nov 22; 31 Suppl 9():41-3. PubMed ID: 8959517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.